2026 Eli Lilly Grand Challenge Info Session: Ovo Labs
The 2026 Eli Lilly and Company Grand Challenge will culminate at Eli Lilly and Company’s global headquarters in Indianapolis, where selected early-stage biotech teams will present their work to Lilly scientists and leaders, compete for $100,000 in non-dilutive funding, and gain direct access to Lilly’s innovation ecosystem.
This year’s theme, “Aging Reimagined — New Health Frontiers,” focuses on advancing functional health and resilience across the aging population. The Challenge will spotlight innovations in Mobility & Frailty, Cognitive & Sensory Health, Immune Resilience, and Regenerative Medicine—targeting measurable improvements in real-world healthspan.
Join this info session to hear from Agata Zielinska, CEO of Ovo Labs, winner of the 2025 Grand Challenge in Women's Health, to learn more about this unique opportunity.
Applications are open to founders and researchers worldwide (no Nucleate affiliation required) and close May 15th, 2026.
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!: